✦ LIBER ✦

Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: A phase I study

✍ Scribed by Borje S. Andersson; Timothy Madden; Hai T. Tran; Wendy W. Hu; Karl G. Blume; Diana S.-L. Chow; Richard E. Champlin; William P. Vaughan

Book ID: 117727868
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 117 KB
Volume: 6
Category: Article
ISSN: 1083-8791
DOI: 10.1016/s1083-8791(00)70064-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hematopoietic stem cell transplantation

Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): A phase I study of the pediatric blood and marrow transplant consortium

✍ Sandler, E.S. ;Hagg, R. ;Coppes, M.J. ;Mustafa, M.M. ;Gamis, A. ;Kamani, N. ;Wal 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 3 views

202: Preliminary Results of a Phase I St

202: Preliminary Results of a Phase I Study of Immuno-Chemotherapy (CTX) Conditioning with Gemtuzumab Ozogamicin (GO), Busulfan (Bu) and Cyclophosphamide (Cy) Followed by Allogeneic Stem Cell Transplantation (AlloSCT) in Pediatric Recipients with High Risk (HR) CD33+ Acute Myelogenous Leukemia (AML)

✍ I. Waxman; M. Bhatia; E. Qualter; Z.Z. Jin; V. Kohl; L. Baldinger; J. Guerra; J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB